{"id":12154,"date":"2025-03-18T10:25:22","date_gmt":"2025-03-18T09:25:22","guid":{"rendered":"https:\/\/iph-multisite.berta-bewegt.ch\/?p=12154"},"modified":"2026-03-03T10:29:56","modified_gmt":"2026-03-03T09:29:56","slug":"medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/","title":{"rendered":"Communiqu\u00e9 de presse: Enqu\u00eate sur l\u2019Europe 2025: malgr\u00e9 certaines incertitudes, la population suisse est favorable au r\u00e9sultat des n\u00e9gociations avec l\u2019UE"},"content":{"rendered":"\n<p class=\"is-style-paragraph-lead-text\"><strong>La 12e enqu\u00eate repr\u00e9sentative de gfs.bern sur mandat d\u2019Interpharma montre que la population suisse continue \u00e0 \u00eatre convaincue des avantages de la voie bilat\u00e9rale et, de m\u00eame que ces derni\u00e8res ann\u00e9es, se prononce clairement en sa faveur. Elle reconna\u00eet les b\u00e9n\u00e9fices d\u2019une relation avec l\u2019UE bien r\u00e9gl\u00e9e et en voit l\u2019importance pour l\u2019\u00e9conomie et la soci\u00e9t\u00e9. Cependant, la situation g\u00e9opolitique actuelle et le discours politique sur les accords bilat\u00e9raux sont sources d\u2019inqui\u00e9tudes croissantes. Bien que le soutien aux accords bilat\u00e9raux n\u2019ait que l\u00e9g\u00e8rement diminu\u00e9, la hausse du nombre de personnes ind\u00e9cises est significative. Une prise de position claire des partis politiques et un engagement intensif du Conseil f\u00e9d\u00e9ral seraient des moyens efficaces de lutter contre les incertitudes.<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-la-population-souhaite-stabilite-et-relations-bien-reglees\"><strong>La population souhaite stabilit\u00e9 et relations bien r\u00e9gl\u00e9es<\/strong><\/h2>\n\n\n\n<p>L\u2019enqu\u00eate de cette ann\u00e9e montre que la majorit\u00e9 de la population souhaite des relations avec ses voisins europ\u00e9ens stables et bien r\u00e9gl\u00e9es dans la dur\u00e9e. Pr\u00e8s de huit personnes interrog\u00e9es sur dix sont d\u2019avis que la Suisse a besoin de solides relations avec l\u2019UE pour pouvoir s\u2019imposer face \u00e0 la concurrence mondiale. La m\u00eame proportion est en faveur de l\u2019introduction d\u2019un processus d\u2019arbitrage d\u2019\u00e9ventuels litiges sur les accords actuels.<\/p>\n\n\n\n<p>Cependant, le discours intensif sur le r\u00e9sultat des n\u00e9gociations entre la Suisse et l\u2019UE s\u2019est sensiblement dynamis\u00e9 depuis que celles-ci se sont mat\u00e9riellement achev\u00e9es en d\u00e9cembre dernier et, de ce fait, la perception des relations bilat\u00e9rales existantes est l\u00e9g\u00e8rement sous pression.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-malgre-des-incertitudes-la-population-voit-des-avantages-nets-aux-accords-bilateraux-iii\"><strong>Malgr\u00e9 des incertitudes, la population voit des avantages nets aux accords bilat\u00e9raux III<\/strong><\/h2>\n\n\n\n<p>Bien que le soutien aux accords bilat\u00e9raux reste clair, la population suisse a conscience des effets de ces accords. Elle attend en particulier que les relations bilat\u00e9rales facilitent l\u2019acc\u00e8s au personnel qualifi\u00e9 dont notre pays a besoin (69% des personnes interrog\u00e9es) et renforcent la place \u00e9conomique suisse (64%). Mais certains redoutent aussi des effets n\u00e9gatifs, par exemple une \u00e9ventuelle pression sur les salaires. Environ la moiti\u00e9 de la population n\u2019est pas s\u00fbre que les accords apportent globalement plus de prosp\u00e9rit\u00e9 \u00e0 la Suisse.<\/p>\n\n\n\n<p>Ces diff\u00e9rences de perception soulignent la n\u00e9cessit\u00e9 de renforcer le travail d\u2019information. En effet, la prosp\u00e9rit\u00e9 de la Suisse repose en grande partie sur le commerce international et l\u2019UE est notre principale partenaire commerciale. En outre, l\u2019UE repr\u00e9sente pour la Suisse l\u2019acc\u00e8s \u00e0 un march\u00e9 de pr\u00e8s de 500 millions de consommatrices et consommateurs, au march\u00e9 int\u00e9rieur europ\u00e9en et \u00e0 un vaste pool de personnel qualifi\u00e9.<\/p>\n\n\n\n<p>D<sup>r<\/sup> Ren\u00e9 Buholzer, directeur d\u2019Interpharma, souligne&nbsp;:<\/p>\n\n\n\n<p><em>\u00ab En ces temps incertains, o\u00f9 plane la menace d\u2019une guerre commerciale des grandes puissances, il est d\u00e9cisif de renforcer la voie suisse et non de la mettre en danger. Des relations contractuelles stables et qui fonctionnent bien avec notre principale partenaire commerciale qu\u2019est l\u2019UE sont essentielles pour la s\u00e9curit\u00e9 et la prosp\u00e9rit\u00e9 de la Suisse. La voie bilat\u00e9rale pr\u00e9sente des avantages dont nous ne saurions nous passer. \u00bb<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La 12e enqu\u00eate repr\u00e9sentative de gfs.bern sur mandat d\u2019Interpharma montre que la population suisse continue \u00e0 \u00eatre convaincue des avantages de la voie bilat\u00e9rale et, de m\u00eame que ces derni\u00e8res ann\u00e9es, se prononce clairement en sa faveur. Elle reconna\u00eet les b\u00e9n\u00e9fices d\u2019une relation avec l\u2019UE bien r\u00e9gl\u00e9e et en voit l\u2019importance pour l\u2019\u00e9conomie et la [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3446,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[122,130,131,145],"class_list":["post-12154","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-communique-de-presse","tag-pharmastandort-2030-fr","tag-politique","tag-les-bilaterales"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Communiqu\u00e9 de presse: Enqu\u00eate sur l\u2019Europe 2025: malgr\u00e9 certaines incertitudes, la population suisse est favorable au r\u00e9sultat des n\u00e9gociations avec l\u2019UE - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Communiqu\u00e9 de presse: Enqu\u00eate sur l\u2019Europe 2025: malgr\u00e9 certaines incertitudes, la population suisse est favorable au r\u00e9sultat des n\u00e9gociations avec l\u2019UE\" \/>\n<meta property=\"og:description\" content=\"La 12e enqu\u00eate repr\u00e9sentative de gfs.bern sur mandat d\u2019Interpharma montre que la population suisse continue \u00e0 \u00eatre convaincue des avantages de la voie bilat\u00e9rale et, de m\u00eame que ces derni\u00e8res ann\u00e9es, se prononce clairement en sa faveur. Elle reconna\u00eet les b\u00e9n\u00e9fices d\u2019une relation avec l\u2019UE bien r\u00e9gl\u00e9e et en voit l\u2019importance pour l\u2019\u00e9conomie et la [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-18T09:25:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T09:29:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/03\/Web-Europabefragung-2025.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"642\" \/>\n\t<meta property=\"og:image:height\" content=\"338\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"berta_admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"berta_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/\"},\"author\":{\"name\":\"berta_admin\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\"},\"headline\":\"Communiqu\u00e9 de presse: Enqu\u00eate sur l\u2019Europe 2025: malgr\u00e9 certaines incertitudes, la population suisse est favorable au r\u00e9sultat des n\u00e9gociations avec l\u2019UE\",\"datePublished\":\"2025-03-18T09:25:22+00:00\",\"dateModified\":\"2026-03-03T09:29:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/\"},\"wordCount\":577,\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/03\/Web-Europabefragung-2025.jpg\",\"keywords\":[\"Communiqu\u00e9 de presse\",\"Pharmastandort 2030\",\"Politique\",\"les bilat\u00e9rales\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/\",\"url\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/\",\"name\":\"Communiqu\u00e9 de presse: Enqu\u00eate sur l\u2019Europe 2025: malgr\u00e9 certaines incertitudes, la population suisse est favorable au r\u00e9sultat des n\u00e9gociations avec l\u2019UE - Interpharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/03\/Web-Europabefragung-2025.jpg\",\"datePublished\":\"2025-03-18T09:25:22+00:00\",\"dateModified\":\"2026-03-03T09:29:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/#primaryimage\",\"url\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/03\/Web-Europabefragung-2025.jpg\",\"contentUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/03\/Web-Europabefragung-2025.jpg\",\"width\":642,\"height\":338},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.interpharma.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communiqu\u00e9 de presse: Enqu\u00eate sur l\u2019Europe 2025: malgr\u00e9 certaines incertitudes, la population suisse est favorable au r\u00e9sultat des n\u00e9gociations avec l\u2019UE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.interpharma.ch\/#website\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.interpharma.ch\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/interpharma_ch\",\"https:\/\/ch.linkedin.com\/company\/interpharma\",\"https:\/\/www.instagram.com\/interpharma_ch\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\",\"name\":\"berta_admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"caption\":\"berta_admin\"},\"sameAs\":[\"https:\/\/interpharma.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Communiqu\u00e9 de presse: Enqu\u00eate sur l\u2019Europe 2025: malgr\u00e9 certaines incertitudes, la population suisse est favorable au r\u00e9sultat des n\u00e9gociations avec l\u2019UE - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/","og_locale":"fr_FR","og_type":"article","og_title":"Communiqu\u00e9 de presse: Enqu\u00eate sur l\u2019Europe 2025: malgr\u00e9 certaines incertitudes, la population suisse est favorable au r\u00e9sultat des n\u00e9gociations avec l\u2019UE","og_description":"La 12e enqu\u00eate repr\u00e9sentative de gfs.bern sur mandat d\u2019Interpharma montre que la population suisse continue \u00e0 \u00eatre convaincue des avantages de la voie bilat\u00e9rale et, de m\u00eame que ces derni\u00e8res ann\u00e9es, se prononce clairement en sa faveur. Elle reconna\u00eet les b\u00e9n\u00e9fices d\u2019une relation avec l\u2019UE bien r\u00e9gl\u00e9e et en voit l\u2019importance pour l\u2019\u00e9conomie et la [&hellip;]","og_url":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/","og_site_name":"Interpharma","article_published_time":"2025-03-18T09:25:22+00:00","article_modified_time":"2026-03-03T09:29:56+00:00","og_image":[{"width":642,"height":338,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/03\/Web-Europabefragung-2025.jpg","type":"image\/jpeg"}],"author":"berta_admin","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"\u00c9crit par":"berta_admin","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/"},"author":{"name":"berta_admin","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818"},"headline":"Communiqu\u00e9 de presse: Enqu\u00eate sur l\u2019Europe 2025: malgr\u00e9 certaines incertitudes, la population suisse est favorable au r\u00e9sultat des n\u00e9gociations avec l\u2019UE","datePublished":"2025-03-18T09:25:22+00:00","dateModified":"2026-03-03T09:29:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/"},"wordCount":577,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/03\/Web-Europabefragung-2025.jpg","keywords":["Communiqu\u00e9 de presse","Pharmastandort 2030","Politique","les bilat\u00e9rales"],"inLanguage":"fr-FR","copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/","url":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/","name":"Communiqu\u00e9 de presse: Enqu\u00eate sur l\u2019Europe 2025: malgr\u00e9 certaines incertitudes, la population suisse est favorable au r\u00e9sultat des n\u00e9gociations avec l\u2019UE - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/03\/Web-Europabefragung-2025.jpg","datePublished":"2025-03-18T09:25:22+00:00","dateModified":"2026-03-03T09:29:56+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/03\/Web-Europabefragung-2025.jpg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2025\/03\/Web-Europabefragung-2025.jpg","width":642,"height":338},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-europabefragung-2025-die-schweizer-bevoelkerung-befuerwortet-das-ergebnis-der-verhandlungen-mit-der-eu-trotz-einiger-unsicherheiten\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Communiqu\u00e9 de presse: Enqu\u00eate sur l\u2019Europe 2025: malgr\u00e9 certaines incertitudes, la population suisse est favorable au r\u00e9sultat des n\u00e9gociations avec l\u2019UE"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818","name":"berta_admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","caption":"berta_admin"},"sameAs":["https:\/\/interpharma.ch"]}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12154","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=12154"}],"version-history":[{"count":1,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12154\/revisions"}],"predecessor-version":[{"id":12155,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12154\/revisions\/12155"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media\/3446"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=12154"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/tags?post=12154"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}